Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation.
about
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium.Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assays.Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis.Bioactivity of enoxaparin in critically ill patients with normal renal function.Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism.Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin.Recent advances in anticoagulant drug delivery.The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assay.Pellets for oral administration of low-molecular-weight heparin.Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.Thrombin generation assays for optimizing low molecular weight heparin dosing in pregnant women at risk of thrombosis--response to Ismail et al.Does Lipid Profile Affect Thrombin Generation During Ramadan Fasting in Patients With Cardiovascular Risks?Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.The Role of Tinzaparin in Oncology.The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients.Thrombin generation test for evaluation of antiplatelet treatment in patients with coronary artery disease after percutaneous coronary intervention.A fluorescent probe assay (Heparin Red) for direct detection of heparins in human plasma.In vitro effects of dalteparin on thrombin generation in canine plasma.Effect of dalteparin administration on thrombin generation kinetics in healthy dogs.Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
P2860
Q33723390-06DA4F0C-0996-4C57-A717-BBEBB24EC9D0Q34558722-E936464D-1E5E-4B69-BC73-C6550DC01CFDQ35549780-2EFD9E3E-DBF7-4234-B52E-78710CF36F35Q36374584-CA74E9C1-ADA5-4F46-BCF3-E7C628FEFB6FQ36390249-5F31A8BE-BF48-4DAE-88BF-18DAC30AEEC8Q37197069-94F5F7A5-3AA1-447B-9AC0-2DD05DD50B0FQ37708829-1DACE250-43F7-4AEE-AD27-8300041B2BE2Q37744931-4F35868A-D6B4-4864-8DC5-871629A3D11DQ38649939-C737E27F-B193-4EA3-9AB5-FC029B3ED78AQ38747529-C2AF1740-19D9-4BD4-B58B-5FA5FC275398Q38869704-3A61937D-67DA-47AD-B3BF-273DE2065F98Q43237799-0ABE60A8-4E71-4040-982A-7259D263608AQ45869709-91606D0A-C975-47B6-8E86-0B2639E8314AQ45876471-FAF56D5B-A270-4361-A0B2-6F3A6E59B418Q46622541-16556623-422D-4EF5-B130-A4A6250E7472Q47201370-C35478CC-8702-4195-ACB8-6BA7748C01FFQ47681124-F5702956-9F2C-4874-B352-8A14E367E715Q47752167-CC296572-4A4B-465E-9CB8-8F75A0618601Q47901992-93A6A4E4-70F2-4EA1-AF1A-EEA0FE02EA35Q50226370-1E2A5D1C-4635-4DD0-A5FD-2D1F7390048BQ50589564-B20243B7-A07D-4B85-8131-52D53AF145B6Q50711158-E737BB02-B7EA-4D6A-B3A2-B742F66A4FE5Q57824809-5E87EF68-8A1F-40D5-A30B-014EFEF5AE13
P2860
Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@en
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@nl
type
label
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@en
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@nl
prefLabel
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@en
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@nl
P2093
P2860
P1476
Effect of the anti-factor Xa a ...... phases of thrombin generation.
@en
P2093
Gerotziafas GT
Petropoulou AD
P2860
P304
P356
10.1111/J.1538-7836.2007.02477.X
P577
2007-05-01T00:00:00Z